Oncology
- 期刊全稱:Oncology
- 簡稱:ONCOLOGY-BASEL
- ISSN:0030-2414
- ESSN:0030-2414
- 研究方向:醫學 - 腫瘤學
投稿咨詢
免費咨詢
2023最新分區
Oncology英文簡介
Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.
Oncology中文簡介
《Oncology》是一本由KARGER出版商出版的專業醫學期刊,該刊創刊于1967年,刊期Bimonthly,該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 3區,小類學科:腫瘤學 4區;在JCR(Journal Citation Reports)分區等級為Q3。該刊發文范圍涵蓋腫瘤學等領域,旨在及時、準確、全面地報道國內外腫瘤學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為3.734,平均審稿速度較慢,6-12周。
中科院分區最新升級版(當前數據版本:2021年12月最新升級版)
大類學科 |
分區 |
小類學科 |
分區 |
Top期刊 |
綜述期刊 |
醫學 |
4區 |
ONCOLOGY
腫瘤學
|
4區
|
否 |
否 |
JCR分區(當前數據版本:2021-2022年最新版)
JCR分區等級 |
JCR所屬學科 |
分區 |
影響因子 |
Q3 |
ONCOLOGY |
Q3 |
3.734 |
期刊指數
影響因子 |
h-index |
Gold OA文章占比 |
研究類文章占比 |
OA開放訪問 |
平均審稿速度 |
3.734 |
92 |
8.72% |
87.91% |
未開放 |
較慢,6-12周 |
IF值(影響因子)趨勢圖